McMillan NA - Search Results

1

RNA-based gene targeting therapies for human papillomavirus driven cancers.

Salinas-Montalvo AM, Supramaniam A, McMillan NA, Idris A. Salinas-Montalvo AM, et al. Among authors: mcmillan na. Cancer Lett. 2021 Dec 28;523:111-120. doi: 10.1016/j.canlet.2021.10.005. Epub 2021 Oct 8. Cancer Lett. 2021. PMID: 34627949 Review.

2

Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.

Gu W, Putral L, Hengst K, Minto K, Saunders NA, Leggatt G, McMillan NA. Gu W, et al. Among authors: mcmillan na. Cancer Gene Ther. 2006 Nov;13(11):1023-32. doi: 10.1038/sj.cgt.7700971. Epub 2006 Jun 30. Cancer Gene Ther. 2006. PMID: 16810314

3

The development and future of oligonucleotide-based therapies for cervical cancer.

Gu W, Putral LN, Irving A, McMillan NA. Gu W, et al. Among authors: mcmillan na. Curr Opin Mol Ther. 2007 Apr;9(2):126-31. Curr Opin Mol Ther. 2007. PMID: 17458165 Review.

4

Combined synthetic and recombinant techniques for the development of lipoprotein-based, self-adjuvanting vaccines targeting human papillomavirus type-16 associated tumors.

Moyle PM, Dai W, Liu TY, Hussein WM, Maruthayanar P, Wells JW, McMillan NA, Skwarczynski M, Toth I. Moyle PM, et al. Among authors: mcmillan na. Bioorg Med Chem Lett. 2015 Dec 1;25(23):5570-5. doi: 10.1016/j.bmcl.2015.10.049. Epub 2015 Oct 19. Bioorg Med Chem Lett. 2015. PMID: 26514746

5

HPV-associated head and neck cancers in the Asia Pacific: A critical literature review & meta-analysis.

Shaikh MH, McMillan NA, Johnson NW. Shaikh MH, et al. Among authors: mcmillan na. Cancer Epidemiol. 2015 Dec;39(6):923-38. doi: 10.1016/j.canep.2015.09.013. Epub 2015 Nov 9. Cancer Epidemiol. 2015. PMID: 26523982 Review.

6

Inhibition of Aurora A and Aurora B Is Required for the Sensitivity of HPV-Driven Cervical Cancers to Aurora Kinase Inhibitors.

Martin D, Fallaha S, Proctor M, Stevenson A, Perrin L, McMillan N, Gabrielli B. Martin D, et al. Mol Cancer Ther. 2017 Sep;16(9):1934-1941. doi: 10.1158/1535-7163.MCT-17-0159. Epub 2017 May 18. Mol Cancer Ther. 2017. PMID: 28522591

7

Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh.

Shaikh MH, Khan AI, Sadat A, Chowdhury AH, Jinnah SA, Gopalan V, Lam AK, Clarke DTW, McMillan NAJ, Johnson NW. Shaikh MH, et al. BMC Cancer. 2017 Nov 25;17(1):792. doi: 10.1186/s12885-017-3789-0. BMC Cancer. 2017. PMID: 29178862 Free PMC article.

8

RNAi Targeting of Human Metapneumovirus P and N Genes Inhibits Viral Growth.

Nitschinsk KM, Clarke DT, Idris A, McMillan NA. Nitschinsk KM, et al. Among authors: mcmillan na. Intervirology. 2018;61(3):149-154. doi: 10.1159/000491927. Epub 2018 Aug 24. Intervirology. 2018. PMID: 30145592 Free article.

9

Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers.

Shaikh MH, Idris A, Johnson NW, Fallaha S, Clarke DTW, Martin D, Morgan IM, Gabrielli B, McMillan NAJ. Shaikh MH, et al. Oral Oncol. 2018 Nov;86:105-112. doi: 10.1016/j.oraloncology.2018.09.006. Epub 2018 Sep 19. Oral Oncol. 2018. PMID: 30409290

10

Development of novel lipidic particles for siRNA delivery that are highly effective after 12 months storage.

Clarke D, Idris A, McMillan NAJ. Clarke D, et al. PLoS One. 2019 Feb 8;14(2):e0211954. doi: 10.1371/journal.pone.0211954. eCollection 2019. PLoS One. 2019. PMID: 30735545 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page